<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37195987</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>19</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>16</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>5</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>A network causal relationship between type-1 diabetes mellitus, 25-hydroxyvitamin D level and systemic lupus erythematosus: Mendelian randomization study.</ArticleTitle><Pagination><StartPage>e0285915</StartPage><MedlinePgn>e0285915</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0285915</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0285915</ELocationID><Abstract><AbstractText Label="BACKGROUND">Observational studies have suggested a relationship between type-1 diabetes mellitus (T1DM) and systemic lupus erythematosus (SLE). In both autoimmunities, 25-hydroxyvitamin D (25-OHD) deficiency is common. However, the causality between T1DM, 25-OHD level and SLE remains largely unknown.</AbstractText><AbstractText Label="METHODS">Independent genetic variants associated with T1DM, 25-OHD level, and SLE from the largest genome-wide association studies were used to conduct two-sample bidirectional Mendelian randomization (BIMR) and two-step Mendelian randomization (MR) analysis to estimate causal relationship between T1DM, 25-OHD level and SLE, and further multivariable Mendelian randomization (MVMR) was used to verify direct causality of T1DM and 25-OHD level on SLE. A series of sensitivity analysis as validation of primary MR results were performed.</AbstractText><AbstractText Label="RESULTS">Consistent with the results of BIMR, there was strong evidence for a direct causal effect of T1DM on the risk of SLE (ORMVMR-IVW = 1.249, 95% CI = 1.148-1.360, PMVMR-IVW = 1.25&#xd7;10-5), and 25-OHD level was negatively associated with the risk of SLE (ORMVMR-IVW = 0.305, 95% CI = 0.109-0.857, PMVMR-IVW = 0.031). We also observed a negative causal effect of T1DM on 25-OHD level (ORBIMR-IVW = 0.995, 95% CI = 0.991-0.999, PBIMR-IVW = 0.030) while the causal effect of 25-OHD level on the risk of T1DM did not exist (PBIMR-IVW = 0.106). In BIMR analysis, there was no evidence for causal effects of SLE on the risk of T1DM and 25-OHD level (PBIMR-IVW &gt; 0.05, respectively).</AbstractText><AbstractText Label="CONCLUSION">Our MR analysis suggested that there was a network causal relationship between T1DM, 25-OHD level and SLE. T1DM and 25-OHD level both have causal associations with the risk of SLE, and 25-OHD level could be a mediator in the causality of T1DM and SLE.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2023 Su et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Kaisheng</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Jilin University, Changchun, Jilin Province, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Epidemiology, The First Hospital of Jilin University, Changchun, Jilin Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jia</LastName><ForeName>Zhifang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Clinical Epidemiology, The First Hospital of Jilin University, Changchun, Jilin Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Yanhua</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Clinical Epidemiology, The First Hospital of Jilin University, Changchun, Jilin Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Yuanlin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Gastrointestinal Surgery, The First Hospital of Jilin University, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Qi</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, The First Hospital of Jilin University, Changchun, Jilin Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Zhenyu</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, The First Hospital of Jilin University, Changchun, Jilin Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Jing</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-0174-9174</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Jilin University, Changchun, Jilin Province, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Epidemiology, The First Hospital of Jilin University, Changchun, Jilin Province, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>A288AR3C9H</RegistryNumber><NameOfSubstance UI="C104450">25-hydroxyvitamin D</NameOfSubstance></Chemical><Chemical><RegistryNumber>P6YZ13C99Q</RegistryNumber><NameOfSubstance UI="D002112">Calcifediol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="Y">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057182" MajorTopicYN="N">Mendelian Randomization Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002112" MajorTopicYN="N">Calcifediol</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>17</Day><Hour>19</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>17</Day><Hour>13</Hour><Minute>35</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37195987</ArticleId><ArticleId IdType="pmc">PMC10191345</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0285915</ArticleId><ArticleId IdType="pii">PONE-D-23-07381</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Posselt RT, Coelho VN, Skare TL. Hashimoto thyroiditis, anti-thyroid antibodies and systemic lupus erythematosus. Int J Rheum Dis. 2018;21(1):186&#x2013;193. doi: 10.1111/1756-185X.13089</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1756-185X.13089</ArticleId><ArticleId IdType="pubmed">28544477</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortes S, Chambers S, Jer&#xf3;nimo A, Isenberg D. Diabetes mellitus complicating systemic lupus erythematosus&#x2014;analysis of the UCL lupus cohort and review of the literature. Lupus. 2008;17(11):977&#x2013;980. doi: 10.1177/0961203308091539</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203308091539</ArticleId><ArticleId IdType="pubmed">18852220</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsokos GC, Lo MS, Costa Reis P, Sullivan KE. New insights into the immunopathogenesis of systemic lupus erythematosus. Nat Rev Rheumatol. 2016;12(12):716&#x2013;730. doi: 10.1038/nrrheum.2016.186</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrrheum.2016.186</ArticleId><ArticleId IdType="pubmed">27872476</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsarou A, Gudbj&#xf6;rnsdottir S, Rawshani A, et al.. Type 1 diabetes mellitus. Nat Rev Dis Primers. 2017;3:17016. doi: 10.1038/nrdp.2017.16</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.16</ArticleId><ArticleId IdType="pubmed">28358037</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciang NC, Pereira N, Isenberg DA. Mixed connective tissue disease-enigma variations?. Rheumatology (Oxford). 2017;56(3):326&#x2013;333. doi: 10.1093/rheumatology/kew265</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/kew265</ArticleId><ArticleId IdType="pubmed">27436003</ArticleId></ArticleIdList></Reference><Reference><Citation>Charoenngam N, Holick MF. Immunologic Effects of Vitamin D on Human Health and Disease. Nutrients. 2020;12(7):2097. doi: 10.3390/nu12072097</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12072097</ArticleId><ArticleId IdType="pmc">PMC7400911</ArticleId><ArticleId IdType="pubmed">32679784</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallagher JC, Rosen CJ. Vitamin D: 100 years of discoveries, yet controversy continues. Lancet Diabetes Endocrinol. 2023;11(5):362&#x2013;374. doi: 10.1016/S2213-8587(23)00060-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(23)00060-8</ArticleId><ArticleId IdType="pubmed">37004709</ArticleId></ArticleIdList></Reference><Reference><Citation>Charoenngam N. Vitamin D and Rheumatic Diseases: A Review of Clinical Evidence. Int J Mol Sci. 2021;22(19):10659. doi: 10.3390/ijms221910659</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms221910659</ArticleId><ArticleId IdType="pmc">PMC8508879</ArticleId><ArticleId IdType="pubmed">34639000</ArticleId></ArticleIdList></Reference><Reference><Citation>Komisarenko YI, Bobryk MI. Vitamin D Deficiency and Immune Disorders in Combined Endocrine Pathology. Front Endocrinol (Lausanne). 2018;9:600. doi: 10.3389/fendo.2018.00600</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2018.00600</ArticleId><ArticleId IdType="pmc">PMC6190873</ArticleId><ArticleId IdType="pubmed">30356853</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam MA, Khandker SS, Alam SS, Kotyla P, Hassan R. Vitamin D status in patients with systemic lupus erythematosus (SLE): A systematic review and meta-analysis. Autoimmun Rev. 2019;18(11):102392. doi: 10.1016/j.autrev.2019.102392</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2019.102392</ArticleId><ArticleId IdType="pubmed">31520805</ArticleId></ArticleIdList></Reference><Reference><Citation>Wahren-Herlenius M, D&#xf6;rner T. Immunopathogenic mechanisms of systemic autoimmune disease. Lancet. 2013;382(9894):819&#x2013;831. doi: 10.1016/S0140-6736(13)60954-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(13)60954-X</ArticleId><ArticleId IdType="pubmed">23993191</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith GD, Ebrahim S. &#x2019;Mendelian randomization&#x2019;: can genetic epidemiology contribute to understanding environmental determinants of disease?. Int J Epidemiol. 2003;32(1):1&#x2013;22. doi: 10.1093/ije/dyg070</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyg070</ArticleId><ArticleId IdType="pubmed">12689998</ArticleId></ArticleIdList></Reference><Reference><Citation>Didelez V, Sheehan N. Mendelian randomization as an instrumental variable approach to causal inference. Stat Methods Med Res. 2007;16(4):309&#x2013;330. doi: 10.1177/0962280206077743</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0962280206077743</ArticleId><ArticleId IdType="pubmed">17715159</ArticleId></ArticleIdList></Reference><Reference><Citation>Sekula P, Del Greco M F, Pattaro C, K&#xf6;ttgen A. Mendelian Randomization as an Approach to Assess Causality Using Observational Data. J Am Soc Nephrol. 2016;27(11):3253&#x2013;3265. doi: 10.1681/ASN.2016010098</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2016010098</ArticleId><ArticleId IdType="pmc">PMC5084898</ArticleId><ArticleId IdType="pubmed">27486138</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S, Davey Smith G, Davies NM, et al.. Guidelines for performing Mendelian randomization investigations. Wellcome Open Res. 2020;4:186. doi: 10.12688/wellcomeopenres.15555.2</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/wellcomeopenres.15555.2</ArticleId><ArticleId IdType="pmc">PMC7384151</ArticleId><ArticleId IdType="pubmed">32760811</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S, Thompson SG. Multivariable Mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects. Am J Epidemiol. 2015;181(4):251&#x2013;260. doi: 10.1093/aje/kwu283</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwu283</ArticleId><ArticleId IdType="pmc">PMC4325677</ArticleId><ArticleId IdType="pubmed">25632051</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanderson E, Richardson TG, Morris TT, Tilling K, Davey Smith G. Estimation of causal effects of a time-varying exposure at multiple time points through multivariable mendelian randomization. PLoS Genet. 2022;18(7):e1010290. doi: 10.1371/journal.pgen.1010290</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1010290</ArticleId><ArticleId IdType="pmc">PMC9348730</ArticleId><ArticleId IdType="pubmed">35849575</ArticleId></ArticleIdList></Reference><Reference><Citation>MacArthur J, Bowler E, Cerezo M, et al.. The new NHGRI-EBI Catalog of published genome-wide association studies (GWAS Catalog). Nucleic Acids Res. 2017;45(D1):D896&#x2013;D901. doi: 10.1093/nar/gkw1133</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw1133</ArticleId><ArticleId IdType="pmc">PMC5210590</ArticleId><ArticleId IdType="pubmed">27899670</ArticleId></ArticleIdList></Reference><Reference><Citation>Onengut-Gumuscu S, Chen WM, Burren O, et al.. Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers. Nat Genet. 2015;47(4):381&#x2013;386. doi: 10.1038/ng.3245</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3245</ArticleId><ArticleId IdType="pmc">PMC4380767</ArticleId><ArticleId IdType="pubmed">25751624</ArticleId></ArticleIdList></Reference><Reference><Citation>Bentham J, Morris DL, Graham DSC, et al.. Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus. Nat Genet. 2015;47(12):1457&#x2013;1464. doi: 10.1038/ng.3434</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3434</ArticleId><ArticleId IdType="pmc">PMC4668589</ArticleId><ArticleId IdType="pubmed">26502338</ArticleId></ArticleIdList></Reference><Reference><Citation>Manousaki D, Mitchell R, Dudding T, et al.. Genome-wide Association Study for Vitamin D Levels Reveals 69 Independent Loci. Am J Hum Genet. 2020;106(3):327&#x2013;337. doi: 10.1016/j.ajhg.2020.01.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2020.01.017</ArticleId><ArticleId IdType="pmc">PMC7058824</ArticleId><ArticleId IdType="pubmed">32059762</ArticleId></ArticleIdList></Reference><Reference><Citation>Relton CL, Davey Smith G. Two-step epigenetic Mendelian randomization: a strategy for establishing the causal role of epigenetic processes in pathways to disease. Int J Epidemiol. 2012;41(1):161&#x2013;176. doi: 10.1093/ije/dyr233</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyr233</ArticleId><ArticleId IdType="pmc">PMC3304531</ArticleId><ArticleId IdType="pubmed">22422451</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmer TM, Lawlor DA, Harbord RM, et al.. Using multiple genetic variants as instrumental variables for modifiable risk factors. Stat Methods Med Res. 2012;21(3):223&#x2013;242. doi: 10.1177/0962280210394459</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0962280210394459</ArticleId><ArticleId IdType="pmc">PMC3917707</ArticleId><ArticleId IdType="pubmed">21216802</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S, Scott RA, Timpson NJ, Davey Smith G, Thompson SG; EPIC- InterAct Consortium. Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors. Eur J Epidemiol. 2015;30(7):543&#x2013;552. doi: 10.1007/s10654-015-0011-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-015-0011-z</ArticleId><ArticleId IdType="pmc">PMC4516908</ArticleId><ArticleId IdType="pubmed">25773750</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator. Genet Epidemiol. 2016;40(4):304&#x2013;314. doi: 10.1002/gepi.21965</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gepi.21965</ArticleId><ArticleId IdType="pmc">PMC4849733</ArticleId><ArticleId IdType="pubmed">27061298</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartwig FP, Davey Smith G, Bowden J. Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption. Int J Epidemiol. 2017;46(6):1985&#x2013;1998. doi: 10.1093/ije/dyx102</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyx102</ArticleId><ArticleId IdType="pmc">PMC5837715</ArticleId><ArticleId IdType="pubmed">29040600</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512&#x2013;525. doi: 10.1093/ije/dyv080</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyv080</ArticleId><ArticleId IdType="pmc">PMC4469799</ArticleId><ArticleId IdType="pubmed">26050253</ArticleId></ArticleIdList></Reference><Reference><Citation>Rees JMB, Wood AM, Burgess S. Extending the MR-Egger method for multivariable Mendelian randomization to correct for both measured and unmeasured pleiotropy. Stat Med. 2017;36(29):4705&#x2013;4718. doi: 10.1002/sim.7492</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.7492</ArticleId><ArticleId IdType="pmc">PMC5725762</ArticleId><ArticleId IdType="pubmed">28960498</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant AJ, Burgess S. Pleiotropy robust methods for multivariable Mendelian randomization. Stat Med. 2021;40(26):5813&#x2013;5830. doi: 10.1002/sim.9156</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.9156</ArticleId><ArticleId IdType="pmc">PMC7612169</ArticleId><ArticleId IdType="pubmed">34342032</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong JS, MacGregor S. Implementing MR-PRESSO and GCTA-GSMR for pleiotropy assessment in Mendelian randomization studies from a practitioner&#x2019;s perspective. Genet Epidemiol. 2019;43(6):609&#x2013;616. doi: 10.1002/gepi.22207</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gepi.22207</ArticleId><ArticleId IdType="pmc">PMC6767464</ArticleId><ArticleId IdType="pubmed">31045282</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanderson E, Spiller W, Bowden J. Testing and correcting for weak and pleiotropic instruments in two-sample multivariable Mendelian randomization. Stat Med. 2021;40(25):5434&#x2013;5452. doi: 10.1002/sim.9133</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.9133</ArticleId><ArticleId IdType="pmc">PMC9479726</ArticleId><ArticleId IdType="pubmed">34338327</ArticleId></ArticleIdList></Reference><Reference><Citation>Censi S, Mian C, Betterle C. Insulin autoimmune syndrome: from diagnosis to clinical management. Ann Transl Med. 2018;6(17):335. doi: 10.21037/atm.2018.07.32</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/atm.2018.07.32</ArticleId><ArticleId IdType="pmc">PMC6174196</ArticleId><ArticleId IdType="pubmed">30306074</ArticleId></ArticleIdList></Reference><Reference><Citation>Lidar M, Braf A, Givol N, et al.. Anti-insulin antibodies and the natural autoimmune response in systemic lupus erythematosus. Lupus. 2001;10(2):81&#x2013;86. doi: 10.1191/096120301669081314</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/096120301669081314</ArticleId><ArticleId IdType="pubmed">11237130</ArticleId></ArticleIdList></Reference><Reference><Citation>Fridkis-Hareli M. Immunogenetic mechanisms for the coexistence of organ-specific and systemic autoimmune diseases. J Autoimmune Dis. 2008;5:1. doi: 10.1186/1740-2557-5-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1740-2557-5-1</ArticleId><ArticleId IdType="pmc">PMC2265707</ArticleId><ArticleId IdType="pubmed">18275618</ArticleId></ArticleIdList></Reference><Reference><Citation>Wucherpfennig KW, Allen PM, Celada F, et al.. Polyspecificity of T cell and B cell receptor recognition. Semin Immunol. 2007;19(4):216&#x2013;224. doi: 10.1016/j.smim.2007.02.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smim.2007.02.012</ArticleId><ArticleId IdType="pmc">PMC2034306</ArticleId><ArticleId IdType="pubmed">17398114</ArticleId></ArticleIdList></Reference><Reference><Citation>Kottyan LC, Maddox A, Braxton JR, et al.. Genetic variants at the 16p13 locus confer risk for eosinophilic esophagitis. Genes Immun. 2019;20(4):281&#x2013;292. doi: 10.1038/s41435-018-0034-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41435-018-0034-z</ArticleId><ArticleId IdType="pmc">PMC6286696</ArticleId><ArticleId IdType="pubmed">29904099</ArticleId></ArticleIdList></Reference><Reference><Citation>Inamo J. Association between celiac disease and systemic lupus erythematosus: a Mendelian randomization study. Rheumatology (Oxford). 2020;59(9):2642&#x2013;2644. doi: 10.1093/rheumatology/keaa071</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keaa071</ArticleId><ArticleId IdType="pubmed">32176771</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin Q, Zhao L, Ren A, et al.. Systemic lupus erythematosus is causally associated with hypothyroidism, but not hyperthyroidism: A Mendelian randomization study. Front Immunol. 2023;14:1125415. doi: 10.3389/fimmu.2023.1125415</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1125415</ArticleId><ArticleId IdType="pmc">PMC9968792</ArticleId><ArticleId IdType="pubmed">36860870</ArticleId></ArticleIdList></Reference><Reference><Citation>Kriegel MA, Manson JE, Costenbader KH. Does vitamin D affect risk of developing autoimmune disease?: a systematic review. Semin Arthritis Rheum. 2011;40(6):512&#x2013;531.e8. doi: 10.1016/j.semarthrit.2010.07.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2010.07.009</ArticleId><ArticleId IdType="pmc">PMC3098920</ArticleId><ArticleId IdType="pubmed">21047669</ArticleId></ArticleIdList></Reference><Reference><Citation>Martens PJ, Gysemans C, Verstuyf A, Mathieu AC. Vitamin D&#x2019;s Effect on Immune Function. Nutrients. 2020;12(5):1248. doi: 10.3390/nu12051248</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12051248</ArticleId><ArticleId IdType="pmc">PMC7281985</ArticleId><ArticleId IdType="pubmed">32353972</ArticleId></ArticleIdList></Reference><Reference><Citation>Rolf L, Muris AH, Hupperts R, Damoiseaux J. Illuminating vitamin D effects on B cells&#x2014;the multiple sclerosis perspective. Immunology. 2016;147(3):275&#x2013;284. doi: 10.1111/imm.12572</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.12572</ArticleId><ArticleId IdType="pmc">PMC4754614</ArticleId><ArticleId IdType="pubmed">26714674</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S, Sims GP, Chen XX, Gu YY, Chen S, Lipsky PE. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol. 2007;179(3):1634&#x2013;1647. doi: 10.4049/jimmunol.179.3.1634</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.179.3.1634</ArticleId><ArticleId IdType="pubmed">17641030</ArticleId></ArticleIdList></Reference><Reference><Citation>Hahn J, Cook NR, Alexander EK, et al.. Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial. BMJ. 2022;376:e066452. doi: 10.1136/bmj-2021-066452</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-066452</ArticleId><ArticleId IdType="pmc">PMC8791065</ArticleId><ArticleId IdType="pubmed">35082139</ArticleId></ArticleIdList></Reference><Reference><Citation>Savastio S, Cadario F, Genoni G, et al.. Vitamin D Deficiency and Glycemic Status in Children and Adolescents with Type 1 Diabetes Mellitus. PLoS One. 2016;11(9):e0162554. doi: 10.1371/journal.pone.0162554</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0162554</ArticleId><ArticleId IdType="pmc">PMC5015862</ArticleId><ArticleId IdType="pubmed">27607348</ArticleId></ArticleIdList></Reference><Reference><Citation>Nascimento BF, Moreira CFF, da Fonseca ER, et al.. Effects of vitamin D supplementation on glycemic control of children and adolescents with type 1 diabetes mellitus: a systematic review. J Pediatr Endocrinol Metab. 2022;35(8):973&#x2013;988. doi: 10.1515/jpem-2022-0044</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/jpem-2022-0044</ArticleId><ArticleId IdType="pubmed">35850934</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin Y, Choi SC, Xu Z, et al.. Normalization of CD4+ T cell metabolism reverses lupus. Sci Transl Med. 2015;7(274):274ra18. doi: 10.1126/scitranslmed.aaa0835</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaa0835</ArticleId><ArticleId IdType="pmc">PMC5292723</ArticleId><ArticleId IdType="pubmed">25673763</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo X, Guo Y, Qian Q, et al.. Mendelian randomization analysis revealed potential causal factors for systemic lupus erythematosus. Immunology. 2020;159(3):279&#x2013;288. doi: 10.1111/imm.13144</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.13144</ArticleId><ArticleId IdType="pmc">PMC7011638</ArticleId><ArticleId IdType="pubmed">31670388</ArticleId></ArticleIdList></Reference><Reference><Citation>Karaoglan M, Nacarkahya G. Clinical and laboratory clues of maturity-onset diabetes of the young and determination of association with molecular diagnosis. J Diabetes. 2021;13(2):154&#x2013;163. doi: 10.1111/1753-0407.13097</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1753-0407.13097</ArticleId><ArticleId IdType="pubmed">32710514</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>